$0.00$0.00 (0.0%)
Healthcare Solutions Management Group, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
Loading market information…
OTC · ASFX · USD
Stock price
Quote as of Oct 28, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
American Scientific Resources, Incorporated’s quoted price sits in the lower half of its reported 52-week range, 70.0% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE COMPANY BEHIND THE TICKER
American Scientific Resources, Incorporated develops, manufactures, assembles, markets, and distributes medical products and devices for children and adults. It offers Thermofocus 5-in-1, a non-contact clinical thermometer; VeraTemp and VeraTemp+ non-contact thermometers; Scald Safe Water temperature disc, a warning disc that helps to ensure that a baby's bath water is at an appropriate temperature; and WhistleWatch, a flow monitoring device that allows parents to monitor their child's respiratory problems. The company also provides Kidz-Med portable ultrasonic nebulizer, which is used to treat asthma, bronchitis, allergies, and sinusitis; Kidz-Med Medicine Dispenser that consists of an orthodontic nipple attached to a medication chamber; and Kidz-Med Mommy Recorder, a voice-recording device, which allows a mother to record a message designed to calm baby when he or she is upset. In addition, it offers Bip DVDs, a video series to help children understand life events; Mebby product line that includes breast pumps, bisphenol A free baby bottles, digital scales, humidifiers, pacifiers, & sterilizers; and Wee Target, a toilet training device for young boys. Further, the company provides Disintegrator, a home needle and lancet destruction device, which enables patients who give themselves injections, including those suffering from multiple sclerosis or diabetes to properly and safely dispose of needles at home. American Scientific Resources distributes its products primarily through retail drug and grocery chains, and medical suppliers, as well as through its Web site and other on-line sites. The company is based in Weston, Florida. On February 27, 2012, an involuntary petition for liquidation under Chapter 7 was filed against American Scientific Resources, Incorporated in the US Bankruptcy Court for the Southern District of Florida. On March 28, 2012, the involuntary petition was approved by the Court. American Scientific Resources, Inc. is in liquidation.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 10:26 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
KEEP COMPARING
$0.00$0.00 (0.0%)
Healthcare Solutions Management Group, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
ViewRay, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
Stem Cell Authority, Ltd.’s quoted price sits in the lower half of its reported 52-week range, 98.67% below the high.
$0.00$0.00 (0.0%)
Scopus BioPharma Inc.’s quoted price sits in the lower half of its reported 52-week range, 96.0% below the high.
$0.00$0.00 (0.0%)
Halo Collective Inc.: Healthcare · Drug Manufacturers - Specialty & Generic.
$0.00$0.00 (0.0%)
RenovaCare, Inc.’s quoted price sits in the lower half of its reported 52-week range, 90.0% below the high.
$0.00$0.00 (0.0%)
Medite Cancer Diagnostics, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
Ceres Ventures, Inc.’s quoted price sits in the lower half of its reported 52-week range, 50.0% below the high.
